Related Experiment Video
Updated: Aug 11, 2026
Spectral Karyotyping to Study Chromosome Abnormalities in Humans and Mice with Polycystic Kidney Disease
Published on: February 3, 2012
Waldenström macroglobulinemia with karyotypic aberrations involving both homologous 6q
1Department of Pathology, Queen Elizabeth Hospital, Hong Kong SAR, China. kfwong@ha.org.hk
Abstract:
An 84-year-old female presenting with proptosis and hyperviscosity syndrome was found to have Waldenström macroglobulinemia. Karyotypic analysis showed structural chromosomal abnormalities involving both homologous chromosomes 6 with a deleted 6q at q21-q23 and a complex three-break rearrangement in the t(6;13;21)?(q21;q14;q11). A literature review suggests that deletions of chromosome 6 at 6q21 are associated with lymphoplasmacytoid differentiation and IgM production in B-cell chronic lymphoproliferative disorders.
Insights
Waldenström macroglobulinemia, a rare B-cell cancer, was diagnosed in an elderly patient with proptosis. Chromosomal abnormalities, including 6q deletion, were identified, linking them to lymphoplasmacytoid differentiation.
Area of Science:
- Hematology
- Clinical Genetics
- Oncology
Background:
- Waldenström macroglobulinemia (WM) is a rare lymphoproliferative disorder characterized by the malignant proliferation of B-lymphocytes that produce monoclonal IgM antibodies.
- Clinical presentation can vary, but hyperviscosity syndrome and proptosis are significant indicators requiring prompt diagnosis and management.
Observation:
- An 84-year-old female presented with proptosis and symptoms of hyperviscosity syndrome.
- Diagnostic workup confirmed Waldenström macroglobulinemia.
- Karyotypic analysis revealed complex chromosomal abnormalities, including a deletion on chromosome 6q (6q21-q23) and a three-break rearrangement t(6;13;21)(q21;q14;q11).
Findings:
- The identified 6q deletion at the 6q21 band is a critical finding.
- Literature suggests a correlation between 6q21 deletions and lymphoplasmacytoid differentiation with IgM production in B-cell chronic lymphoproliferative disorders.
- The complex rearrangement involving chromosomes 6, 13, and 21 may play a role in the pathogenesis of WM in this patient.
Implications:
- These cytogenetic findings contribute to understanding the molecular basis of Waldenström macroglobulinemia.
- The association of 6q deletions with specific cellular features may aid in prognostication and therapeutic strategies for WM.
- Further research into these chromosomal abnormalities could identify novel therapeutic targets for B-cell malignancies.
